BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 253 filers reported holding BIONTECH SE in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $594 | -99.9% | 4,147 | -0.3% | 0.01% | 0.0% |
| Q3 2022 | $561,000 | -10.2% | 4,160 | +9.5% | 0.01% | 0.0% |
| Q2 2022 | $625,000 | +6.3% | 3,798 | -0.7% | 0.01% | +25.0% |
| Q1 2022 | $588,000 | -2.8% | 3,825 | -1.1% | 0.00% | 0.0% |
| Q4 2021 | $605,000 | -48.0% | 3,866 | -7.5% | 0.00% | -42.9% |
| Q3 2021 | $1,163,000 | -73.7% | 4,178 | -68.7% | 0.01% | -73.1% |
| Q2 2021 | $4,429,000 | +91.7% | 13,347 | -0.1% | 0.03% | +85.7% |
| Q1 2021 | $2,310,000 | +65.7% | 13,355 | +3.9% | 0.01% | +55.6% |
| Q4 2020 | $1,394,000 | +28.5% | 12,852 | +5.1% | 0.01% | +12.5% |
| Q3 2020 | $1,085,000 | -11.3% | 12,231 | +4.2% | 0.01% | -11.1% |
| Q2 2020 | $1,223,000 | +129.9% | 11,739 | +5.4% | 0.01% | +80.0% |
| Q1 2020 | $532,000 | – | 11,133 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |